CLINICAL_TRIALS
trial_result
· 2017-05-05
Clinical Trial Update: Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. [Phase 2]
Summary
A double-blind Phase 2 pilot trial evaluated mirtazapine for co-occurring Major Depressive Disorder and Alcohol Use Disorder. The study has completed and result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05